These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32923492)

  • 41. Mixed-Effects Models with Skewed Distributions for Time-Varying Decay Rate in HIV Dynamics.
    Chen R; Huang Y
    Commun Stat Simul Comput; 2016; 45(2):737-757. PubMed ID: 26924880
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparing Smoothing Techniques for Fitting the Nonlinear Effect of Covariate in Cox Models.
    Roshani D; Ghaderi E
    Acta Inform Med; 2016 Feb; 24(1):38-41. PubMed ID: 27041809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Weighted Dirichlet Process Mixture Models to Accommodate Complex Sample Designs for Linear and Quantile Regression.
    Elliott MR; Xia X
    J Off Stat; 2021 Mar; 37(1):71-95. PubMed ID: 34483435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coming Together of Bayesian Inference and Skew Spherical Data.
    Nakhaei Rad N; Bekker A; Arashi M; Ley C
    Front Big Data; 2021; 4():769726. PubMed ID: 35224481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Bayesian multivariate mixture model for skewed longitudinal data with intermittent missing observations: An application to infant motor development.
    Allen C; Benjamin-Neelon SE; Neelon B
    Biometrics; 2021 Jun; 77(2):675-688. PubMed ID: 34305152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A nonparametric method to generate synthetic populations to adjust for complex sampling design features.
    Dong Q; Elliott MR; Raghunathan TE
    Surv Methodol; 2014 Jun; 40(1):29-46. PubMed ID: 29200608
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bayesian proportional hazards model with time-varying regression coefficients: a penalized Poisson regression approach.
    Lambert P; Eilers PH
    Stat Med; 2005 Dec; 24(24):3977-89. PubMed ID: 16320263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficient estimation of a linear transformation model for current status data via penalized splines.
    Lu M; Liu Y; Li CS
    Stat Methods Med Res; 2020 Jan; 29(1):3-14. PubMed ID: 30592240
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Robust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trials.
    Ternès N; Rotolo F; Michiels S
    BMC Med Res Methodol; 2017 May; 17(1):83. PubMed ID: 28532387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Smoothness selection for penalized quantile regression splines.
    Reiss PT; Huang L
    Int J Biostat; 2012 May; 8(1):Article 10. PubMed ID: 22628358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An efficient penalized estimation approach for semiparametric linear transformation models with interval-censored data.
    Lu M; Liu Y; Li CS; Sun J
    Stat Med; 2022 May; 41(10):1829-1845. PubMed ID: 35099078
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Semiparametric location estimation under non-random sampling.
    Genton MG; Kim M; Ma Y
    Stat; 2012 Aug; 1(1):1-11. PubMed ID: 24532858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. On the impact of model selection on predictor identification and parameter inference.
    Pfeiffer RM; Redd A; Carroll RJ
    Comput Stat; 2017; 32(2):667-690. PubMed ID: 28690368
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Applying sample survey methods to clinical trials data.
    LaVange LM; Koch GG; Schwartz TA
    Stat Med; 2001 Sep 15-30; 20(17-18):2609-23. PubMed ID: 11523072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bayesian nonparametric quantile process regression and estimation of marginal quantile effects.
    Xu SG; Reich BJ
    Biometrics; 2023 Mar; 79(1):151-164. PubMed ID: 34611897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bayesian central statistical monitoring using finite mixture models in multicenter clinical trials.
    Hatayama T; Yasui S
    Contemp Clin Trials Commun; 2020 Sep; 19():100566. PubMed ID: 32685763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Measures of the Degree of Departure from Ignorable Sample Selection.
    Little RJA; West BT; Boonstra PS; Hu J
    J Surv Stat Methodol; 2020 Nov; 8(5):932-964. PubMed ID: 33381610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Skew-normal/independent linear mixed models for censored responses with applications to HIV viral loads.
    Bandyopadhyay D; Lachos VH; Castro LM; Dey DK
    Biom J; 2012 May; 54(3):405-25. PubMed ID: 22685005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Comparison of Bayesian Spatial Models for HIV Mapping in South Africa.
    Ayalew KA; Manda S; Cai B
    Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769735
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Zero-augmented beta-prime model for multilevel semi-continuous data: a Bayesian inference.
    Kamyari N; Soltanian AR; Mahjub H; Moghimbeigi A; Seyedtabib M
    BMC Med Res Methodol; 2022 Nov; 22(1):283. PubMed ID: 36324066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.